| Identification | |
| Name: | Retrorsine-N-oxide |
| Synonyms: | Isatidine(6CI,7CI); Retrorsine, N-oxide (8CI); Senecionan-11,16-dione, 12,18-dihydroxy-,4-oxide; Retrorsine oxide |
| CAS: | 15503-86-3 |
| Molecular Formula: | C18H25 N O7 |
| Molecular Weight: | 367.396 |
| InChI: | InChI=1/C18H25NO7/c1-3-12-8-11(2)18(23,10-20)17(22)25-9-13-4-6-19(24)7-5-14(15(13)19)26-16(12)21/h3-4,11,14-15,20,23H,5-10H2,1-2H3/t11-,14-,15?,18-,19?/m1/s1 |
| Molecular Structure: |  |
| Properties | |
| Transport: | 1544 |
| Melting Point: | 138 DEGdeg C (Decomp) |
| Flash Point: | °C |
| Boiling Point: | °Cat760mmHg |
| Density: | g/cm3 |
| Solubility: | Sol in water and ethanol; sparingly sol in non-polar solvents In water, 5,200 mg/L @ 25 deg C /Estimated/ |
| Specification: |
Retrorsine-N-oxide (CAS NO.15503-86-3) is also called 12,18-Dihydroxysenecionan-11,16-dione 4-oxide ; 12,18-Dihydroxysenecionan-11,16-dione-4-oxide ; 4-27-00-06664 (Beilstein Handbook Reference) ; BRN 0058804 ; CCRIS 4339 ; HSDB 3499 ; Isatidine ; Retrorsine N-oxide ; Retrorsine oxide ; Senecionan-11,16-dione, 12,18-dihydroxy-, 4-oxide ; cis-Retronecic acid ester of retronecine-N-oxide ; trans-15-Ethylidene-12beta-hydroxy-12alpha-hydroxymethyl- |
| Report: |
IARC Cancer Review: Group 3 IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 ,1987,p. 56.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 10 ,1976,p. 269.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . |
| Packinggroup: | II |
| Flash Point: | °C |
| Color: | Colorless prisms |
| Safety Data | |
 |
|
